Mukesh Harisinghani, MD
Diagnostic Radiology · Boston, MANPI 1659345361
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,342,249 of the $1,367,649 with a category attached, or 98.1%. Perspectum Diagnostics Ltd accounts for 74.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $384,238 and has fallen 97.0% since, to $11,711 in 2025. Among diagnostic radiology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 330 payments — averaging $4144.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Perspectum Diagnostics Ltd$1M
- Merck$291K
- Siemens Medical Solutions USA, Inc.$22K
- Vertex$13K
- Eisai Inc.$8K
- Pfizer$6K
- plus $14K from 5 others
Across 328 payments — averaging $3373.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$312K
- E.r. Squibb & Sons, L.L.C.$183K
- Takeda Pharmaceuticals U.S.A., Inc.$117K
- GE HealthCare$106K
- Siemens Medical Solutions USA, Inc.$94K
- Dr.reddy's Laboratories,inc.$75K
- plus $220K from 12 others
What the payments were for
- Consulting fees$1,342,24998%
- Speaking & faculty fees$18,4081%
- Travel & lodging$5,6670%
- Food & beverage$5670%
- Entertainment$7580%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Perspectum Diagnostics Ltd | 54 | $1,012,148 |
| Merck | 232 | $291,401 |
| Siemens Medical Solutions USA, Inc. | 17 | $22,210 |
| Vertex | 5 | $13,230 |
| Eisai Inc. | 7 | $8,120 |
| Pfizer | 6 | $6,060 |
| AMAG Pharmaceuticals, Inc. | 2 | $3,615 |
| Bayer | 1 | $3,250 |
| GSK | 3 | $2,951 |
| Eli Lilly | 1 | $2,800 |
| GE HealthCare | 2 | $1,865 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LiverMultiScan$1,012,022
- KEYTRUDA$260,611
- MK-7684$16,260
- Ontak$8,050
- LORBRENA$6,060
- syngo Virtual Cockpit$1,663
- MK-7339$1,638
- MAGNETOM Vida$1,004
- FERAHEME$165
How this compares
$1,367,649 in reported general payments places this provider in the 95th percentile of 1,206 diagnostic radiology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other diagnostic radiology in Boston
- Gregg MillerBoston$1.8M
- Stephan AndersonBoston$1.6M
- Ashraf ThabetBoston$1.4M
- Andrew KompelBoston$1.3M
- Elaine IuanowBoston$590K
- Subba DigumarthyBoston$561K
- Michael SteignerBoston$504K
- Jennifer UyedaBoston$412K
- Victorine MuseBoston$364K
- Michael ZalisBoston$273K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.